Galectin Therapeutics Files 8-K
Ticker: GALT · Form: 8-K · Filed: Dec 20, 2024 · CIK: 1133416
| Field | Detail |
|---|---|
| Company | Galectin Therapeutics INC (GALT) |
| Form Type | 8-K |
| Filed Date | Dec 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, financials
TL;DR
GALECTIN THERAPEUTICS INC. filed an 8-K on 12/20/2024. Standard corporate update.
AI Summary
Galectin Therapeutics Inc. filed an 8-K on December 20, 2024, reporting other events and financial statements. The company, formerly known as Pro Pharmaceuticals Inc., is incorporated in Nevada and headquartered in Norcross, Georgia.
Why It Matters
This filing provides an update on Galectin Therapeutics' corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine corporate filing (8-K) that does not appear to contain significant new material events or financial disclosures beyond standard reporting requirements.
Key Numbers
- 001-31791 — SEC File Number (Identifies the company's filing history with the SEC.)
- 04-3562325 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- GALECTIN THERAPEUTICS INC. (company) — Registrant
- PRO PHARMACEUTICALS INC (company) — Former company name
- December 20, 2024 (date) — Date of report
- Norcross, GA (location) — Principal executive office location
- Nevada (location) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves to report 'Other Events' and 'Financial Statements and Exhibits' as of December 20, 2024.
When was Galectin Therapeutics Inc. previously known by another name?
Galectin Therapeutics Inc. was formerly known as PRO PHARMACEUTICALS INC, with a date of name change on June 12, 2001.
Where is Galectin Therapeutics Inc. headquartered?
The company's principal executive office is located at 4960 PEACHTREE INDUSTRIAL BOULEVARD, STE 240, NORCROSS, GA 30071.
In which U.S. state is Galectin Therapeutics Inc. incorporated?
Galectin Therapeutics Inc. is incorporated in Nevada.
What is the SIC code for Galectin Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Galectin Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 415 words · 2 min read · ~1 pages · Grade level 10.5 · Accepted 2024-12-20 07:50:19
Key Financial Figures
- $0.001 — hange on which registered Common Stock $0.001par value per share GALT The Nasdaq
Filing Documents
- ef20040433_8k.htm (8-K) — 27KB
- ef20040433_ex99-1.htm (EX-99.1) — 19KB
- image00001.jpg (GRAPHIC) — 5KB
- 0001140361-24-050005.txt ( ) — 195KB
- galt-20241220.xsd (EX-101.SCH) — 4KB
- galt-20241220_lab.xml (EX-101.LAB) — 21KB
- galt-20241220_pre.xml (EX-101.PRE) — 16KB
- ef20040433_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Items. On December 20, 2024 , Galectin Therapeutics Inc. (the "Company) issued the press release attached hereto as Exhibit 99.1, and incorporated herein by reference. SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release dated December 20, 2024
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Galectin Therapeutics Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Galectin Therapeutics Inc. Date: December 20, 2024 By: /s/ Jack W. Callicutt Jack W. Callicutt Chief Financial Officer